Zahra Heidari, Ali Moghtaderi, Hamidreza Mahmoudzadeh-Sagheb and Enam Alhagh Charkhat Gorgich
’s disease are predominantly associated with serotonin and dopamine. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2010;34(6):1104-14. DOI: 10.1016/j.pnpbp.2010.06.004
4. Mounsey RB, Teismann P. Mitochondrial dysfunction in Parkinson’s disease: pathogenesis and neuroprotection. Parkinson’s Disease. 2010;2011.
5. Sato K, Hatano T, Yamashiro K, Kagohashi M, Nishioka K, Izawa N, et al. Prognosis of Parkinson’s disease: time to stage III, IV, V, and to motor fluctuations. Movement disorders. 2006;21(9):1384-95. DOI: 10.1002/mds